A ò mọ ohun tó máa ń fa àrùn jẹjẹrẹ kòkòrò yìí ní pàtó, àmọ́ wọ́n ti ṣàwárí àwọn nǹkan bíi mélòó kan tó lè mú kí àrùn náà le sí i.
Lára àwọn nǹkan wọ̀nyí ni:
1. Ọ̀dọ́mọkùnrin: Bí wọ́n ṣe ń dàgbà sí i, bẹ́ẹ̀ ni ewu àrùn jẹjẹrẹ kòkòrò yìí máa ń pọ̀ sí i, èyí tó pọ̀ jù lọ nínú wọn ló sì jẹ́ ọkùnrin tó ti pé ọmọ ọdún márùn-ún.
2. Ìtàn Ìdílé: Àwọn ọkùnrin tí ìdílé wọn ti ní àrùn jẹjẹrẹ kòkòrò kòkòrò kòkòrò kòkòrò, pàápàá jù lọ bàbá tàbí arákùnrin wọn tó ní àrùn náà, ló wà nínú ewu tó ga jù lọ.
3. Ẹ̀yà: Àwọn ọkùnrin ọmọ ilẹ̀ Áfíríkà tó jẹ́ ọmọ ilẹ̀ Amẹ́ríkà ní ewu tó ga jù lọ láti ní àrùn jẹjẹrẹ kòkòrò jẹjẹrẹ ju àwọn ọkùnrin tó jẹ́ ọmọ ẹ̀yà mìíràn lọ.
4. Oúnjẹ: Oúnjẹ tó ní ọ̀pọ̀lọpọ̀ ọ̀rá, àgàgà ọ̀rá ẹranko, lè mú kí àrùn jẹjẹrẹ kòkòrò jẹjẹrẹ pọ̀ sí i.
5. Ìwọ̀n tó pọ̀ jù: Bí èèyàn bá sanra ju bó ṣe yẹ lọ tàbí tó sanra ju bó ṣe yẹ lọ, ó lè mú kí àrùn jẹjẹrẹ kòkòrò jẹjẹrẹ pọ̀ sí i.
6. Àwọn èròjà tó ń fa àrùn jẹjẹrẹ: Àwọn èròjà tó ń fa àrùn jẹjẹrẹ àti àwọn èròjà mìíràn tó ń fa àrùn jẹjẹrẹ lè mú kí àrùn jẹjẹrẹ máa pọ̀ sí i.
7. Ìpalára: Ìpalára tí kò lópin nínú kòkòrò kòkòrò kòkòrò kòkòrò, irú bí àrùn kòkòrò kòkòrò kòkòrò, lè mú kí ewu àrùn jẹjẹrẹ kòkòrò kòkòrò tókòrò kòkòrò pọ̀ sí i.
8. Àmì àbùdá: Àwọn àyípadà àbùdá kan tí wọ́n jogún, irú bí èyí tó wà nínú àbùdá BRCA1 àti BRCA2, lè mú kí ewu àrùn jẹjẹrẹ kòkòrò kòkòrò lè pọ̀ sí i.
Ó ṣe pàtàkì láti ṣàkíyèsí pé lílo ọ̀kan tàbí jù bẹ́ẹ̀ lọ lára àwọn ohun tó ń fa ewu yìí kò túmọ̀ sí pé ọkùnrin kan máa ní àrùn jẹjẹrẹ kòkòrò kòkòrò kòkòrò, ọ̀pọ̀ ọkùnrin tó ní àrùn jẹjẹrẹ kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò kòkòrò.
Yàtọ̀ síyẹn, wọ́n tún ń ṣe ìwádìí láti lóye ohun tó ń fa àrùn jẹjẹrẹ kòkòrò náà, kí wọ́n sì mọ àwọn nǹkan mìíràn tó lè fa àrùn náà.
Riihimäki M, Thomsen H, Brandt A, Sundquist J, Hemminki K: What do prostate cancer patients die of? Oncologist. 2011, 16 (2): 175-81.
Gilligan T: Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control. 2005, 16 (1): 45-53.
Newschaffer CJ, Otani K, McDonald MK, Penberthy LT: Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort. J Natl Cancer Inst. 2000, 92 (8): 613-21.
Frydenberg M, Wijesinha S: Diagnosing prostate cancer - what GPs need to know. Aust Fam Physician. 2007, 36 (5): 345-7.
Shimodaira K, Nakashima J, Nakagami Y, Hirasawa Y, Hashimoto T, Satake N, Gondo T, Namiki K, Ohori M, Ohno Y: Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy. Urol J. 2020, 17 (1): 42-49.
Martínez-Salamanca JI, Ballesteros CM, Carballido Rodríguez J: [Epidemiological fundamentals of clinically localized prostate cancer]. Arch Esp Urol. 2011, 64 (8): 703-10.
Ìyàsímímọ́: ìtọ́jú ìlera
Oju opo wẹẹbu yii ni a pese fun eto-ẹkọ ati awọn idi alaye nikan ati pe ko ṣe agbekalẹ pese imọran iṣoogun tabi awọn iṣẹ ọjọgbọn.
A ò gbọ́dọ̀ lo ìsọfúnni tó wà nínú ìwé náà láti ṣe àyẹ̀wò tàbí láti wo àìsàn tàbí àìsàn kan wò, àwọn tó bá sì ń wá ìmọ̀ràn nípa ìṣègùn fúnra wọn gbọ́dọ̀ bá dókítà tó ní ìwé àṣẹ sọ̀rọ̀.
Jọwọ ṣe akiyesi nẹtiwọọki neural ti o ṣe agbejade awọn idahun si awọn ibeere, jẹ pataki ti ko tọ nigbati o ba de si akoonu nọmba. Fun apẹẹrẹ, nọmba awọn eniyan ti a ṣe ayẹwo pẹlu aisan kan pato.
Nigbagbogbo wa imọran ti dokita rẹ tabi olupese ilera ti o ni oye miiran nipa ipo iṣoogun kan. Maṣe gbagbe imọran iṣoogun ọjọgbọn tabi idaduro ni wiwa rẹ nitori nkan ti o ti ka lori oju opo wẹẹbu yii. Ti o ba ro pe o le ni pajawiri iṣoogun, pe 911 tabi lọ si yara pajawiri ti o sunmọ julọ lẹsẹkẹsẹ. Ko si ibatan dokita-aisan ti a ṣẹda nipasẹ oju opo wẹẹbu yii tabi lilo rẹ. Bẹni BioMedLib tabi awọn oṣiṣẹ rẹ, tabi ẹnikẹni ti o ṣe alabapin si oju opo wẹẹbu yii, ṣe eyikeyi awọn aṣoju, ṣalaye tabi tumọ, pẹlu ọwọ si alaye ti a pese nibi tabi lilo rẹ.
Ìyàsímímọ́: ẹ̀tọ́ ọmọnìyàn
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the DMCA) n pese atunṣe fun awọn onihun aṣẹ-aṣẹ ti o gbagbọ pe ohun elo ti o han lori Intanẹẹti ṣe ilokulo awọn ẹtọ wọn labẹ ofin aṣẹ-aṣẹ AMẸRIKA.
Ti o ba gbagbọ ni igbagbọ to dara pe eyikeyi akoonu tabi ohun elo ti o wa ni asopọ pẹlu oju opo wẹẹbu wa tabi awọn iṣẹ ṣe ilokulo aṣẹ-aṣẹ rẹ, iwọ (tabi aṣoju rẹ) le firanṣẹ akiyesi kan si wa ti o beere pe a yọ akoonu tabi ohun elo naa kuro, tabi idilọwọ iraye si rẹ.
A gbọdọ firanṣẹ awọn iwifunni ni kikọ nipasẹ imeeli (wo abala "Ibaṣepọ" fun adirẹsi imeeli).
DMCA nilo pe akiyesi rẹ ti ilokulo aṣẹ-aṣẹ ti a fi ẹsun kan pẹlu alaye wọnyi: (1) apejuwe ti iṣẹ ti o ni aṣẹ-aṣẹ ti o jẹ koko-ọrọ ti ilokulo ti a fi ẹsun kan; (2) apejuwe ti akoonu ti a fi ẹsun kan ati alaye ti o to lati gba wa laaye lati wa akoonu naa; (3) alaye olubasọrọ fun ọ, pẹlu adirẹsi rẹ, nọmba foonu ati adirẹsi imeeli; (4) alaye nipasẹ rẹ pe o ni igbagbọ rere pe akoonu ni ọna ti o ni ẹsun ti ko ni aṣẹ nipasẹ eni aṣẹ-aṣẹ, tabi aṣoju rẹ, tabi nipasẹ iṣẹ ti ofin eyikeyi;
(5) ìpolongo kan láti ọ̀dọ̀ rẹ, tí o fìdí rẹ̀ múlẹ̀ lábẹ́ ìjìyà ẹ̀rí èké, pé ìsọfúnni tó wà nínú ìkéde náà tọ̀nà àti pé o ní àṣẹ láti mú kí àwọn ẹ̀tọ́ ọmọnìyàn tí wọ́n sọ pé wọ́n ti rú ṣẹ ṣẹ;
ati (6) ibuwọlu ti ara tabi itanna ti ẹni ti o ni aṣẹ tabi eniyan ti o ni aṣẹ lati ṣiṣẹ ni orukọ ẹni ti o ni aṣẹ.
Ti o ko ba ṣafikun gbogbo alaye ti o wa loke le ja si idaduro ti ṣiṣe ẹdun rẹ.
Ìfọ̀rọ̀wérọ̀
Jọwọ fi imeeli ranṣẹ si wa pẹlu eyikeyi ibeere / imọran.
What causes prostate cancer?
The exact cause of prostate cancer is not known, but several factors have been identified that may increase the risk of developing the disease.
These include:
1. Age: The risk of prostate cancer increases with age, with most cases occurring in men over the age of 65.
2. Family history: Men with a family history of prostate cancer, particularly a father or brother with the disease, are at a higher risk.
3. Race: African American men have a higher risk of developing prostate cancer than men of other races.
4. Diet: A diet high in fat, particularly animal fat, may increase the risk of prostate cancer.
5. Obesity: Being overweight or obese may increase the risk of developing prostate cancer.
6. Hormones: High levels of testosterone and other male hormones may increase the risk of prostate cancer.
7. Inflammation: Chronic inflammation of the prostate, such as prostatitis, may increase the risk of prostate cancer.
8. Genetics: Certain inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, may increase the risk of prostate cancer.
It is important to note that having one or more of these risk factors does not mean that a man will definitely develop prostate cancer, and many men with prostate cancer have no known risk factors.
Additionally, research is ongoing to better understand the causes of prostate cancer and identify additional risk factors.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Ní nǹkan bí
BioMedLib nlo awọn kọnputa adaṣe (awọn alugoridimu ẹkọ ẹrọ) lati ṣe agbejade awọn tọkọtaya ibeere ati idahun.
A bẹrẹ pẹlu awọn atẹjade biomedical miliọnu 35 ti PubMed/Medline. Pẹlupẹlu, awọn oju-iwe wẹẹbu ti RefinedWeb.
